Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: Detection of Minimal Residual Disease Post-prostatectomy

View source ↗

Summary

This clinical trial entry describes a study evaluating detection of minimal residual disease after prostatectomy in prostate cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Radboud University Medical Center | Conditions: Prostate Cancer | Status: RECRUITING